Drug intelligence / Profile preview

Sleep&Go

Development stage: Unknown
Lead developer: Laboratoires Ortis
Modality: Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration: Oral

Overview

**Sleep&Go** is an oral, plant-based dietary supplement from **Laboratoires Ortis** intended to support sleep onset and sleep quality in people with sleep difficulties, including difficulty falling asleep and nocturnal awakenings. Its formulation contains dry extracts of lemon balm (*Melissa officinalis*), California poppy (*Eschscholzia californica*), hop (*Humulus lupulus*), and passionflower (*Passiflora incarnata*). Ortis describes the botanical combination as promoting relaxation, facilitating sleep onset, and improving sleep quality. ([shop.ortis.com](https://shop.ortis.com/fr/sommeil/40063516-sleepgo-5411386894131.html))

Brand names: Sleep&Go
Other names: Sleep & GOSleep&GO

Beyond the preview

Go deeper on Sleep&Go.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sleep&Go.

Explore the full profile